0
935
Last: 2y
1
1.8k
Last: 4y
Eric Reibe Update
Jake Weingarten
1 mo ago
started 9/2024
0
644
Last: 1mo
0
3.7k
Last: 2y
0
855
Last: 2y
Jeremiah Bembry
Jake Weingarten
3 yr ago
started 10/2021
0
1.4k
Last: 3y
Kamari Lands Louisville?
Jake Weingarten
3 yr ago
started 10/2021
0
1.6k
Last: 3y
Austin Nunez
Jake Weingarten
3 yr ago
started 9/2021
0
1.7k
Last: 3y
Jaden Schutt update
Jake Weingarten
3 yr ago
started 8/2021
0
1.4k
Last: 3y
Ernest Udeh Jr.
Jake Weingarten
3 yr ago
started 8/2021
0
1.3k
Last: 3y
Kentucky/Nick Smith Jr.
Jake Weingarten
3 yr ago
started 7/2021
0
1.9k
Last: 3y
0
1.2k
Last: 3y
The First of Many To Come!
Matt Cleveland
3 yr ago
started 7/2021
0
1.2k
Last: 3y
0
1.2k
Last: 3y
0
2.2k
Last: 3y
0
1.1k
Last: 3y
Enoch Boakye favorite?
Jake Weingarten
3 yr ago
started 3/2021
0
2.0k
Last: 3y
Nimari Burnett-Illinois?
Jake Weingarten
3 yr ago
started 1/2021
0
3.5k
Last: 3y
0
1.5k
Last: 3y
(VIP) Bryce Lindsay
Jake Weingarten
3 yr ago
started 1/2021
2
1.4k
Last: 3y
(VIP) Jaden Schutt
Jake Weingarten
3 yr ago
started 1/2021
0
1.4k
Last: 3y
Nimari Burnett transfer
Jake Weingarten
3 yr ago
started 1/2021
0
1.5k
Last: 3y
Charles Bediako
Jake Weingarten
3 yr ago
started 12/2020
0
2.0k
Last: 3y
Arizona State on the verge?
Jake Weingarten
3 yr ago
started 12/2020
0
1.4k
Last: 3y
Aminu Mohammed
Jake Weingarten
3 yr ago
started 11/2020
2
1.6k
Last: 3y
Keon Edwards DePaul
Jake Weingarten
3 yr ago
started 12/2020
0
1.7k
Last: 3y
Jonas Aidoo
Jake Weingarten
3 yr ago
started 12/2020
0
1.5k
Last: 3y
Jameel Brown intel
Jake Weingarten
3 yr ago
started 12/2020
0
1.6k
Last: 3y
Trevor Keels
Jake Weingarten
3 yr ago
started 11/2020
0
1.6k
Last: 3y
Charles Bediako
Jake Weingarten
3 yr ago
started 11/2020
0
1.6k
Last: 3y
Tae Davis
Jake Weingarten
3 yr ago
started 11/2020
0
2.4k
Last: 3y
Blake Wesley
Jake Weingarten
3 yr ago
started 11/2020
0
1.5k
Last: 3y
Fletcher Loyer
Jake Weingarten
3 yr ago
started 11/2020
0
2.3k
Last: 3y
Page 1
 
×
subscribe Verify your student status
See Subscription Benefits
Trial only available to users who have never subscribed or participated in a previous trial.